Most Read Articles
Elvira Manzano, 29 May 2018
Repeat doses of the intrathecal antisense oligonucleotide nusinersen in children with infantile-onset spinal muscular atrophy (SMA) continue to demonstrate safety, according to  early data from the phase III SHINE extension study, bringing considerable hope to the SMA community.
Audrey Abella, 29 Aug 2018
The combination of the alkylating nitrosourea compound lomustine and the monoclonal antibody bevacizumab prolonged progression-free survival (PFS) in patients with progressive glioblastoma compared with either drug alone, a meta-analysis has shown.
31 Aug 2018
New drug applications approved by US FDA as of 16 - 31 August 2018 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
29 Aug 2018
The risk of traumatic brain injury (TBI) is elevated in young people with attention-deficit/hyperactivity disorder (ADHD), though long-term ADHD medication can reduce this risk, a recent study has found.

Discharge to home uncommon in elderly

04 Mar 2018
The government will focus on building "community networks" to support those with dementia instead.

Less than 20 percent of elderly adults in immediate care facilities are discharged to their homes, a recent Japan study reports. Older age, need for greater care and the presence of several medical conditions are among the factors that appear to be significantly related to discharge to home.

Researchers accessed the information of 342,758 elderly individuals (mean age 84.3±8.2 years; 31.4 percent male) admitted to geriatric immediate care centres. Over the 2-year follow-up, only 65,210 participants (19.0 percent) were discharged to home.

In comparison, 21.0 percent (n=72,047) were transferred to a hospital, 10.2 percent (n=34,879) were transferred to other long-term care (LTC) facilities, 1.4 percent (n=4,674) were transferred to another place, 3.7 percent (n=12,659) died, and 7.0 percent (n=23,954) were discharged but were missing destination information.

After 1 year, the cumulative incidence of discharge to home was only 20.7 percent (95 percent CI, 20.5–20.8).

The multivariable competing-risk Cox proportional hazards regression model showed that older age (hazard ratio [HR] per 1-year increase, 0.98; 0.98–0.98; p<0.001), higher level of care needed (HR for level 5 vs level 1, 0.51; 0.49–0.53; p<0.001) and the presence of dementia (HR, 0.68; 0.65–0.72; p<0.001) were all associated with a decreased likelihood of discharge to home.

In comparison, males (HR, 1.07; 1.05–1.09; p<0.001) and those who received home-based LTC services a month before admission (HR, 2.53; 2.46–2.61; p<0.001) were more likely to be discharged to home.

Editor's Recommendations
Most Read Articles
Elvira Manzano, 29 May 2018
Repeat doses of the intrathecal antisense oligonucleotide nusinersen in children with infantile-onset spinal muscular atrophy (SMA) continue to demonstrate safety, according to  early data from the phase III SHINE extension study, bringing considerable hope to the SMA community.
Audrey Abella, 29 Aug 2018
The combination of the alkylating nitrosourea compound lomustine and the monoclonal antibody bevacizumab prolonged progression-free survival (PFS) in patients with progressive glioblastoma compared with either drug alone, a meta-analysis has shown.
31 Aug 2018
New drug applications approved by US FDA as of 16 - 31 August 2018 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
29 Aug 2018
The risk of traumatic brain injury (TBI) is elevated in young people with attention-deficit/hyperactivity disorder (ADHD), though long-term ADHD medication can reduce this risk, a recent study has found.